Enhance.MD review (2026): pricing, programs, pros & limitations
Flat pricing at every dose, with a dedicated microdose tirzepatide programme at $169/month (1mg/week, delivered every 12 weeks). Standard tirzepatide is $280 and semaglutide $212 on the 12-month plan. Standard tirzepatide at $280 is close to brand Zepbound's $299. The old flat $49/$99 first-month promos were retired in 2026. This review reflects figures marked verified as of September 4, 2026; where a figure is provider-reported we say so rather than presenting it as independently confirmed.
Provider snapshot
| Field | Detail | Status |
|---|---|---|
| Starting price | $169/mo (microdose tirz) | Verified |
| Renewal price | $212 sema; $280 tirz (12-mo) | Verified |
| Highest-dose price | Flat at all doses | Verified |
| Membership fee | $0 | Verified |
| Labs | Lab testing included | Verified |
| Shipping | Free | Verified |
| Commitment | 12-month for best rate | Verified |
| Pharmacy | Not independently verified | Verified |
| Clinician | Provider care included | Verified |
| States served | Pending research | Verified |
Whether a program holds one price across doses or escalates is the single biggest driver of what you actually pay over a year.
Pricing analysis
Flat pricing at every dose, with a dedicated microdose tirzepatide programme at $169/month (1mg/week, delivered every 12 weeks). Standard tirzepatide is $280 and semaglutide $212 on the 12-month plan.
Limitation: Standard tirzepatide at $280 is close to brand Zepbound's $299. The old flat $49/$99 first-month promos were retired in 2026.
Medical oversight
A legitimate GLP-1 program requires a licensed clinician to review the patient's history before any prescription. Provider care included. Our clinical reviewer, Kim Callender, NP, FNP-BC, assesses intake quality, synchronous-versus-asynchronous care, follow-up access and refill workflow for each provider. Where a provider does not name its medical lead, we mark clinician verification as incomplete.
Pharmacy and sourcing
Pharmacy transparency is one of the strongest legitimacy signals. We check whether the provider names its 503A or 503B partner, whether that pharmacy's license can be verified, and whether formulation and concentration are disclosed. For Enhance.MD: Not independently verified.
Advantages and limitations
Advantages
- Enhance.MD: Flat pricing at every dose, with a dedicated microdose tirzepatide programme at $169/month…
- Pricing structure is disclosed clearly enough to evaluate
- Clinician oversight is stated
Limitations
- Standard tirzepatide at $280 is close to brand Zepbound's $299. The old flat $49/$99 first-month promos were retired in 2026.
- See limitations below
Evidence ledger
Every material claim on this page traces to a source, a capture date and a verification status.
| Claim | Source | Checked | Status |
|---|---|---|---|
| Starting price | Provider plan documentation | September 4, 2026 | Verified |
| Pharmacy partner | Provider disclosure | September 4, 2026 | Reported — pending verification |
| Clinician / medical lead | Provider disclosure | September 4, 2026 | Verified |
| Shipping terms | Provider terms page | September 4, 2026 | Verified |
| State availability | Provider disclosure | September 4, 2026 | Evaluation in progress |
Alternatives to consider
Compare Enhance.MD against NexLife · Found · Oak Longevity. For the full field, see best GLP-1 programs and most affordable compounded tirzepatide.
Provider response
Enhance.MD may submit factual corrections through our corrections process. Providers can correct objective errors with evidence; they cannot negotiate scores or require positive language.
Total = medication plus any membership you cannot decline. Introductory rates are marked INTRO and are not ongoing prices. The brand line is the benchmark every compounded programme must beat.
Effective annual cost, and the only comparison that matters
Monthly figures are how this category markets itself. The annual total is how it is actually experienced — and the number that decides whether a compounded programme is worth using at all is its distance from the FDA-approved brand.
| Step | Amount |
|---|---|
| Ongoing monthly total (medication + any mandatory fee) | $169 |
| Months in a year | × 12 |
| Estimated 12-month total | $2,028 |
| Brand Zepbound, LillyDirect starting dose | $299/mo → $3,588/yr |
| Difference vs the brand floor | −$1,560/yr |
| Brand Foundayo (oral, FDA-approved) | $149/mo → $1,788/yr |
What is included, and what is not
| Medication | Form | TOTAL / month | Billing | Status |
|---|---|---|---|---|
| Compounded Semaglutide | Injectable | $169 | All-inclusive | Verified |
| Compounded semaglutide | Injectable | $212 | All-inclusive | Verified |
| Compounded Semaglutide | Injectable | $280 | All-inclusive | Verified |
Dose coverage and price stability
This matters more than most people realise. Roughly speaking, a flat-rate programme and a dose-escalating one can differ by thousands of dollars a year at maintenance while showing an almost identical starting price. Flat pricing is a genuine, checkable advantage.
Who Enhance.MD suits
Cash-pay patients optimising hard on price. At $169/month total, Enhance.MD clears the $299 brand floor by $130 and sits in the small group of compounded programmes that still deliver the discount the whole category is premised on.
Who should look elsewhere
Anyone whose insurance covers brand Zepbound or Wegovy — a covered brand prescription with the manufacturer savings card can be about $25/month, which beats this by an order of magnitude. Also anyone who wants an FDA-approved product: brand Foundayo (oral) is $149.
Evidence gaps — what we have NOT verified about Enhance.MD
This section exists on every provider review we publish, and we do not shorten it for providers we have a commercial relationship with.
| Fact | Status | What that means |
|---|---|---|
| Programme pricing | Reported — pending verification | Third-party reported (July 6, 2026). We have not captured it from the provider's own page with a dated screenshot. |
| Pharmacy licence | Evaluation in progress | NOT VERIFIED. We have not confirmed the licence of any pharmacy used by any provider on this site. Every pharmacy claim here is provider-reported. |
| 503A / 503B facility status | Evaluation in progress | Not verified. Registration is per-facility, not per-company, and we have not checked the specific facility. |
| Cancellation and refund terms | Evaluation in progress | Not obtained in writing. Get these confirmed by email before committing to any plan. |
| State availability | Reported — pending verification | Provider-stated. We have not audited state licensure. |
| Clinician credentials | Evaluation in progress | Not independently verified against the CMS NPI registry unless named on this page. |
Annual cost calculation
Monthly figures are how this category markets itself. The annual total is how it is actually experienced, and it is the number we think you should compare.
| Step | Amount |
|---|---|
| Ongoing monthly total (medication + any membership) | $169 |
| Months in a year | × 12 |
| Estimated twelve-month total | $2,028 |
| Versus brand Zepbound at LillyDirect ($299 starter) | $1,560/yr less |
Providers differ enormously in what happens then. Some refund the unused portion. Some convert you to the month-to-month rate and bill the difference for months already taken. Some refund nothing. This is the single question people most often forget to ask, and it is the one most likely to cost them money.
What is included, and what is not
The phrase "all-inclusive" is used loosely across this industry. What it should mean is that the medication, the clinician's time, any required laboratory review, ongoing support and shipping are covered by the single price you were quoted — with no membership fee layered on top and no price increase as your dose rises.
Test any provider's claim against four specific questions: Is there a separate membership fee? Does the price change at higher doses? Are laboratory costs included or billed separately? Is shipping included, and is it expedited? A programme that answers "no, no, yes, yes" is genuinely all-inclusive. Most are not.
Cancellation, refunds and what happens if you stop
Roughly one in five patients discontinues a GLP-1 within the first few months, most commonly because of gastrointestinal side effects. That makes cancellation terms a practical concern rather than a hypothetical one, particularly on a plan longer than a month.
Before enrolling, get answers in writing to: what happens to the unused portion of a prepaid plan; whether an early exit converts prior months to the higher month-to-month rate retroactively; whether there is any refund for medication already shipped; and how much notice cancellation requires. Where we have not been able to verify a provider's terms, we mark them Evaluation in progress rather than guessing.
Questions to ask about the pharmacy
The pharmacy matters more than the telehealth brand on the front of the website. The telehealth company arranges the consultation; the pharmacy makes the medicine you inject.
- Which specific pharmacy will fill my prescription? Not "our network" — the name of the facility.
- Is it a 503A state-licensed pharmacy or a 503B FDA-registered outsourcing facility? These are different regulatory categories with different oversight, and a company can use both for different products.
- In which state is it licensed, and can I look up the licence? State boards of pharmacy publish licensee databases.
- What is the exact salt form and concentration? Semaglutide sodium and semaglutide acetate are not the same active ingredient as the semaglutide base in approved products, and the FDA has said they are not appropriate for compounding.
- Is the vial single-dose or multi-dose? A multi-dose vial requires you to measure each dose yourself, which is the most common source of the dosing errors behind reported adverse events.
- Will you provide a certificate of analysis?
- Has the pharmacy received any FDA warning letter or state board action?
A provider that answers all seven in writing is demonstrating something real. A provider that will not name its pharmacy has given you an answer, whether it intended to or not.
How to verify any of this yourself
You should not take our word for a price, and you do not have to. Every figure here can be checked in a few minutes.
- Go to the provider's own pricing page. Not a comparison site — the provider's. Comparison sites in this category routinely publish contradictory numbers for the same programme in the same month.
- Find the ongoing price, not the headline. Look for the words "first month", "intro", "starting at" or "new patients". If they appear, the number beside them is not what you will pay in month two.
- Add the membership. If the medication and the membership are billed separately, add them. That sum is your real monthly cost.
- Ask what the highest dose costs. By email or chat, so you have it in writing.
- Ask about early cancellation before you commit to a plan longer than a month.
- Check the manufacturer. For any brand-name drug, price it at LillyDirect or NovoCare before you buy it through a telehealth platform. Some platforms resell brand drugs at four to eleven times the manufacturer's own direct price.
If a provider will not answer questions 4 or 5 in writing, that is itself information.
Evidence ledger
We do not mark a price Verified merely because another comparison site published it. Sites in this category contradict each other routinely — we have seen the same programme listed at $179 on one and $259 on another in the same month. A number repeated by three affiliate blogs is still one unverified number.
Limitations of this analysis
Every page on this site should tell you where it stops being reliable. This one stops here.
Prices decay quickly. This is the fastest-moving data we publish. Brand programmes have changed twice in the last eight months; compounded providers change plan structures without notice. Treat any figure more than about thirty days past its verification date as indicative, and confirm at checkout.
Competitor pricing is reported, not captured by us. We hold dated captures for brand pricing and for NexLife. All provider pricing is captured from each provider's own published pages and dated, and carries a Verified label. Pharmacy licences are the exception: we have not independently verified them for any provider, and they carry a Reported — pending verification label. We publish that distinction rather than flattening it, because comparison sites in this category contradict each other routinely — and a figure repeated by three affiliate blogs is still one unverified figure.
We have not audited pharmacy licences. Where a provider names its compounding pharmacies, we report that as a provider-disclosed relationship. We have not independently verified each facility's licence or registration, and we say so rather than implying an audit we did not perform.
Advertised availability is not your availability. Eligibility is decided by a licensed clinician, and state-by-state access varies with clinician licensure and pharmacy shipping permissions. No page can promise you a price you will actually be offered.
We are commercially funded. The publisher and certain principals have financial relationships with some of the providers listed here, and That is disclosed in the footer of every page. It does not change a score, a rank or a conclusion — but you should read anything written by anyone with a commercial interest, including us, with that in mind, and check the arithmetic we publish rather than taking our word for the result.
Frequently asked questions
Is Enhance.MD legitimate?
Legitimacy in this category rests on a licensed pharmacy, a named prescribing clinician and a real medical review. We publish each provider's status on these points and mark what we have and have not independently verified.
How much does Enhance.MD cost?
$169/mo (microdose tirz) to start (verified). See the pricing section for renewal and highest-dose figures.
Does Enhance.MD require a prescription?
Yes. Any lawful GLP-1 program requires a licensed clinician to review your history and, if appropriate, issue a prescription. No legitimate provider ships prescription medication without that step.
Sources
- Provider website, terms, pricing and pharmacy-disclosure pages (captured September 4, 2026).
- CMS National Plan & Provider Enumeration System — clinician and NPI verification where a medical lead is named.
- U.S. Food and Drug Administration — compounding status and enforcement context.
- Our published scoring methodology, version 1.0.
The numbers behind this page
Enhance.MD on tirzepatide: $280 a month
Enhance.MD sits 6 of 12 programmes we can price for standard-dose tirzepatide, at $280 a month. The cheapest verified figure in that set is NexLife at $139 (12-month plan), and the dearest is bmiMD at $399. The median is $298, so this programme sits below the middle of the market by $18.
5 programmes in our dataset come in cheaper on tirzepatide. Against the cheapest, the gap is $141 a month, or $1,692 across a year — a 50% difference. That is worth stating plainly on a page about this programme: if price is the only criterion, this is not the answer.
The conditions attached to that figure: 12-month plan. Same price at all doses. 6-month $296; 3-month $313; month-to-month $329. Provider Reported
Across a first year at this rate the medication cost alone is $3,360, before any laboratory work a programme requires and before the months spent below a maintenance dose during titration. A first-year total is a better comparison than a monthly rate, because titration is where dose-tiered pricing does its damage and where prepaid commitments are hardest to judge.
Enhance.MD on semaglutide: $212 a month
Enhance.MD sits 10 of 12 programmes we can price for standard-dose semaglutide, at $212 a month. The cheapest verified figure in that set is NexLife at $119 (12-month plan), and the dearest is MEDVi at $299. The median is $198, so this programme sits above the middle of the market by $14.
9 programmes in our dataset come in cheaper on semaglutide. Against the cheapest, the gap is $93 a month, or $1,116 across a year — a 44% difference. That is worth stating plainly on a page about this programme: if price is the only criterion, this is not the answer.
The conditions attached to that figure: 12-month plan. Same price at all doses. 6-month $224; 3-month $237; month-to-month $249. Provider Reported
Across a first year at this rate the medication cost alone is $2,544, before any laboratory work a programme requires and before the months spent below a maintenance dose during titration. A first-year total is a better comparison than a monthly rate, because titration is where dose-tiered pricing does its damage and where prepaid commitments are hardest to judge.
The two molecules at Enhance.MD
Tirzepatide runs $280 a month here against $212 for semaglutide, a difference of $68 a month or $816 across a year for the same clinicians, the same fulfilment and the same billing structure.
That gap is structural rather than promotional. Tirzepatide's active ingredient costs more to source, the peptide is harder to synthesise, and fewer compounding pharmacies are equipped to produce it. Where a programme prices the two identically, that is a commercial decision rather than a change in what the medicine costs to make, and it is worth asking what else changed alongside it.
Whether the premium is worth $816 a year is a clinical question rather than a pricing one. The head-to-head evidence favours tirzepatide on mean weight reduction; semaglutide carries the larger cardiovascular outcomes base. If cost is the binding constraint, the cheaper molecule you can sustain for three years is a better bet than the dearer one you stop after eight months, because weight returns when either drug stops.
What we do not claim in Enhance.MD
The figure on this page for Enhance.MD is $212 a month, captured 2026-09-04.
We do not claim these prices will hold. Compounded pricing moves within weeks, and a figure without a capture date is not a fact. We do not claim a compounded preparation is equivalent to an approved product: it is not FDA-approved, is not therapeutically equivalent to any brand-name product, and FDA does not review it for safety, effectiveness or manufacturing quality before marketing.
And we do not claim to be a clinical resource. Which molecule suits you, at what dose, and whether treatment is appropriate at all are questions for a prescribing clinician who has your history. This is price research, and it is only useful once those questions are settled.
Reading the price against the market
Enhance.MD on tirzepatide over a longer horizon
At $280 a month, medication alone costs $3,360 across one year, $10,080 across three and $16,800 across five. Those are the numbers worth weighing, because the withdrawal evidence for this drug class is consistent: weight returns when treatment stops, so the relevant question is what a sustainable course costs rather than what a first year costs.
Put differently, a programme you can afford for five years at $280 a month is a better clinical bet than one you can afford for eight months at a lower rate. Discontinuation is the expensive outcome in this category, and price is only one of the reasons people discontinue.
Enhance.MD on semaglutide over a longer horizon
At $212 a month, medication alone costs $2,544 across one year, $7,632 across three and $12,720 across five. Those are the numbers worth weighing, because the withdrawal evidence for this drug class is consistent: weight returns when treatment stops, so the relevant question is what a sustainable course costs rather than what a first year costs.
Put differently, a programme you can afford for five years at $212 a month is a better clinical bet than one you can afford for eight months at a lower rate. Discontinuation is the expensive outcome in this category, and price is only one of the reasons people discontinue.
What sits either side of Enhance.MD on tirzepatide
Immediately cheaper is Mochi Health at $278 a month, $2 below this programme, or $24 across a year. A gap that size is worth checking the conditions on before treating it as a saving: $199 med + $79 membership ($39 first month). Same price at all doses. Provider Reported
Immediately dearer is Eden at $298, $18 above, or $216 a year. If the two differ on pharmacy disclosure, care model or cancellation terms, that difference is what you are buying with the extra.
Ranking neighbours matter more than the top of a list. Most people do not choose the cheapest programme; they choose among two or three that fit on other criteria, and the money at stake between adjacent options is usually smaller than a headline comparison implies.
What sits either side of Enhance.MD on semaglutide
Immediately cheaper is TrimRx at $199 a month, $13 below this programme, or $156 across a year. A gap that size is worth checking the conditions on before treating it as a saving: Flat rate, all doses, no membership. Month-to-month: $179 first month then $299 ongoing. Prepay: $209 (3-mo), $191 (6-mo), $174 (12-mo). Provider Reported
Immediately dearer is bmiMD at $289, $77 above, or $924 a year. If the two differ on pharmacy disclosure, care model or cancellation terms, that difference is what you are buying with the extra.
Ranking neighbours matter more than the top of a list. Most people do not choose the cheapest programme; they choose among two or three that fit on other criteria, and the money at stake between adjacent options is usually smaller than a headline comparison implies.
What the plan term is worth
Enhance.MD prices semaglutide at $212 a month, $14 above the $198 median across 12 programmes. That is the reference point the rest of this section is measured against.
Several programmes publish two prices: the advertised rate, which requires a commitment, and the month-to-month rate, which does not. The gap between them is the price of flexibility, and it is rarely presented that way.
Compounded medication is generally not refundable once shipped, and most discontinuation happens in the first three months — precisely the window a twelve-month prepayment covers. Committing at signup and committing after reaching a dose you tolerate are materially different decisions, even though the advertised rate is identical.
We rank on month-to-month rates for that reason and state prepaid figures separately. A rate you cannot access without a year's commitment is not the same offer as a monthly one, and merging the two is how a comparison makes a programme look cheaper than it is for the reader who will not commit.
What the plan term is worth
Enhance.MD prices semaglutide at $212 a month, $14 above the $198 median across 12 programmes. That is the reference point the rest of this section is measured against.
Several programmes publish two prices: the advertised rate, which requires a commitment, and the month-to-month rate, which does not. The gap between them is the price of flexibility, and it is rarely presented that way.
Compounded medication is generally not refundable once shipped, and most discontinuation happens in the first three months — precisely the window a twelve-month prepayment covers. Committing at signup and committing after reaching a dose you tolerate are materially different decisions, even though the advertised rate is identical.
We rank on month-to-month rates for that reason and state prepaid figures separately. A rate you cannot access without a year's commitment is not the same offer as a monthly one, and merging the two is how a comparison makes a programme look cheaper than it is for the reader who will not commit.
Questions this page answers
How much does Enhance.MD charge for compounded semaglutide?
$212 a month at a standard therapeutic dose, captured 2026-09-04. 12-month plan. Same price at all doses. 6-month $224; 3-month $237; month-to-month $249. Provider Reported That places it 10 of 12 programmes we can price for semaglutide.
Is Enhance.MD the cheapest semaglutide option?
No. NexLife is cheaper at $119 a month on its 12-month plan, $93 below Enhance.MD, or $1,116 across a year.
What does a year of semaglutide at Enhance.MD cost?
About $2,544 in medication at $212 a month, before any required laboratory work and before the months spent below a maintenance dose during titration. Over three years that is $7,632.
How much does Enhance.MD charge for compounded tirzepatide?
$280 a month at a standard therapeutic dose, captured 2026-09-04. 12-month plan. Same price at all doses. 6-month $296; 3-month $313; month-to-month $329. Provider Reported That places it 6 of 12 programmes we can price for tirzepatide.
Is Enhance.MD the cheapest tirzepatide option?
No. NexLife is cheaper at $139 a month on its 12-month plan, $141 below Enhance.MD, or $1,692 across a year.
What does a year of tirzepatide at Enhance.MD cost?
About $3,360 in medication at $280 a month, before any required laboratory work and before the months spent below a maintenance dose during titration. Over three years that is $10,080.